Condition: Surgical Site Infection · Sponsor: Aesculap AG
The aim of the study is to elucidate, if the colonization of bacteria is lower on the Novosyn® CHD suture compared to uncoated Polyglactin 910 suture, which will be assessed by the incidence of surgical site infections (SSI: A1 and A2). The results of this registry will generate further clinical evidence for the use and the benefit of a Chlorhexidine coated suture used to close the wound after an emergency or elective laparoscopic or laparotomy surgery. The benefit for individual patients lies in the early diagnosis of complications and in the optimized postoperative controls of a clinical study.
This description comes directly from the study's public registry record.
Jaume Garcia Lopez · +34935866200 · info@bbraun.com
Ricard Rosique · info@bbraun.com
Always discuss trial participation with your own doctor first.
| Pineta Grande Hospital | Naples, Italy | Recruiting |
| Hospital Clínico San Carlos | Madrid, Spain | Recruiting |
| Hospital Universitario de Canarias | Santa Cruz de Tenerife, Spain | Recruiting |
| Hospital Universitario Virgen del Rocío | Seville, Spain | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05966961